Work

Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls (P8-2.003)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000210390

Authors: Fumihiro Takahashi, Angela Genge, Takatomo Yoneoka, Manabu Hirai, Daniel Selness, Vesna Todorovic, Art Wamil, Nissim Sasson, Stephen Apple, Ushirogawa Yoshiteru

Institutions: Tanabe Pharma Corporation (Japan), Montreal Neurological Institute and Hospital

Language: English

Topic: Amyotrophic Lateral Sclerosis Research

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409227850

FWCI:

Cites:

Cited by:

Related to: 10